Multicenter phase II trial of topotecan, cisplatin and bevacizumab for recurrent or persistent cervical cancer

Autor: Zighelboim, Israel a, ⁎, Wright, Jason D. b, Gao, Feng c, Case, Ashley S. d, Massad, L. Stewart a, Mutch, David G. a, Powell, Matthew A. a, Thaker, Premal H. a, Eisenhauer, Eric L. e, Cohn, David E. e, Valea, Fidel A. f, Alvarez Secord, Angeles f, Lippmann, Lynne T. a, Dehdashti, Farrokh g, Rader, Janet S. h
Zdroj: In Gynecologic Oncology July 2013 130(1):64-68
Databáze: ScienceDirect
Externí odkaz: